JMA Chief Pushes September 2019 Drug Price Announcement for Ad-Hoc Revision

December 27, 2018
JMA President Yoshitake Yokokura The government should announce new NHI drug prices for its October 2019 ad-hoc re-pricing in early September, instead of March as widely rumored in the industry, Yoshitake Yokokura, president of the Japan Medical Association (JMA), said...read more